SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) "

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
41.
  • Nozohoor, Shahab, et al. (författare)
  • ABO blood group does not impact incidence or outcomes of surgery for acute type A aortic dissection
  • 2019
  • Ingår i: Scandinavian Cardiovascular Journal. - Taylor & Francis. - 1401-7431.
  • Tidskriftsartikel (refereegranskat)abstract
    • Objectives. To evaluate the distribution and impact of ABO blood groups on postoperative outcomes in patients undergoing surgery for acute type A aortic dissection (ATAAD). Design. A total of 1144 surgical ATAAD patients from eight Nordic centres constituting the Nordic consortium for acute type A aortic dissection (NORCAAD) were analysed. Blood group O patients were compared to non-O subjects. The relative frequency of blood groups was assessed with t-distribution, modified for weighted proportions. Multivariable logistic regression was performed to identify independent predictors of 30-day mortality. Cox regression analyses were performed for assessing independent predictors of late mortality. Results. There was no significant difference in the proportions of blood group O between the study populations in the NORCAAD registry and the background population (40.6 (95% CI 37.7–43.4)% vs 39.0 (95% CI 39.0–39.0)%). ABO blood group was not associated with any significant change in risk of 30-day or late mortality, with the exception of blood group A being an independent predictor of late mortality. Prevalence of postoperative complications was similar between the ABO blood groups. Conclusions. In this large cohort of Nordic ATAAD patients, there were no associations between ABO blood group and surgical incidence or outcomes, including postoperative complications and survival.
42.
  • Huvila, J., et al. (författare)
  • Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma
  • 2018
  • Ingår i: Gynecologic Oncology. - Academic Press Inc.. - 0090-8258. ; 149:1, s. 173-180
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: In clinical practise, prognostication of endometrial cancer is based on clinicopathological risk factors. The use of immunohistochemistry-based markers as prognostic tools is generally not recommended and a systematic analysis of their utility as a panel is lacking. We evaluated whether an immunohistochemical marker panel could reliably assess endometrioid endometrial cancer (EEC) outcome independent of clinicopathological information. Methods: A cohort of 306 EEC specimens was profiled using tissue microarray (TMA). Cost- and time-efficient immunohistochemical analysis of well-established tissue biomarkers (ER, PR, HER2, Ki-67, MLH1 and p53) and two new biomarkers (L1CAM and ASRGL1) was carried out. Statistical modelling with embedded variable selection was applied on the staining results to identify minimal prognostic panels with maximal prognostic accuracy without compromising generalizability. Results: A panel including p53 and ASRGL1 immunohistochemistry was identified as the most accurate predictor of relapse-free and disease-specific survival. Within this panel, patients were allocated into high- (5.9%), intermediate- (29.5%) and low- (64.6%) risk groups where high-risk patients had a 30-fold risk (P < 0.001) of dying of EEC compared to the low-risk group. Conclusions: P53 and ASRGL1 immunoprofiling stratifies EEC patients into three risk groups with significantly different outcomes. This simple and easily applicable panel could provide a useful tool in EEC risk stratification and guiding the allocation of treatment modalities. 
  •  
43.
  • Sofizadeh, Sheyda, et al. (författare)
  • Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
  • 2019
  • Ingår i: Diabetes Therapy. - Springer. - 1869-6953. ; 10:6, s. 2115-2130
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: The effects of the GLP-1 analogue liraglutide on time in hypoglycaemia, time in hyperglycaemia, and time in range for type 2 diabetes patients initially treated with multiple daily insulin injections (MDI) were investigated. Variables associated with hypoglycaemia in the current population were also identified. Methods: Analyses were based on data from a previously performed double-blind, placebo-controlled trial in which 124 MDI-treated patients with type 2 diabetes were randomized to liraglutide or placebo. Masked continuous glucose monitoring (CGM) was performed at baseline and week 24 in 99 participants. Results: The mean time in hypoglycaemia was similar for participants receiving liraglutide and those receiving placebo after 24 weeks of treatment. Mean time in target was greater in the liraglutide group than in the placebo group: 430 versus 244 min/24 h (p < 0.001) and 960 versus 695 min/24 h (p < 0.001) for the two glycaemic ranges considered, 4–7 mmol/l and 4–10 mmol/l, respectively. Mean time in hyperglycaemia was lower in the liraglutide group: 457 versus 723 min/24 h (p = 0.001) and 134 versus 264 min/24 h (p = 0.023) for the two cutoffs considered, > 10 mmol/l and > 14 mmol/l, respectively. Lower mean glucose level, lower C-peptide, and higher glucose variability were associated with an increased risk of hypoglycaemia in both treatment groups. Higher proinsulin level was associated with a lower risk of hypoglycaemia in the liraglutide group. Conclusion: For type 2 diabetes patients initially treated with MDI, introducing liraglutide had a beneficial effect on glucose profiles estimated by masked CGM. Mean glucose level, glycaemic variability, C-peptide, and proinsulin level influenced the risk of hypoglycaemia in this population. Trial Registration: ClinicalTrials.gov, number (EudraCT nr: 2012-001941-42). Funding: Novo Nordisk funded this study. The Diabetes Research Unit, NU-Hospital Group funded the journal’s Rapid Service Fee.
44.
  • Belfrage, Per, et al. (författare)
  • Dispersion of viable pig liver cells with collagenase
  • 1975
  • Ingår i: Life Sciences. - Elsevier. - 1879-0631. ; 17:8, s. 1219-1225
  • Tidskriftsartikel (refereegranskat)abstract
    • Viable suspended hepatocytes were prepared from surgical biopsy specimens of pig and human liver by digestion with collagenase. Initial perfusion of the tissue through cannulated blood vessels with 0.5 mM EGTA followed by 0.2% collagenase gave the best results. 20−870 × 106 cells of which 60–95 % excluded trypan blue were obtained from 5–30 g pig liver pieces, while results with human liver specimens were usually less satisfactory. In some experiments, however, viable cells, as judged by vital stain exclusion and ability to synthesize lipids were obtained in sufficient yield. In the pig hepatocytes glycerolipid synthesis from [3H] glycerol and oxidation and esterification of [14C] oleic acid had the same characteristics as those observed earlier in rat hepatocytes.
  •  
45.
  •  
46.
47.
48.
  • Matson, Sophia, et al. (författare)
  • Nonattendance in mammographic screening: a study of intraurban differences in Malmo, Sweden, 1990-1994
  • 2001
  • Ingår i: Cancer Detection and Prevention. - Elsevier. - 0361-090X. ; 25:2, s. 132-137
  • Tidskriftsartikel (refereegranskat)abstract
    • Mammographic screening may reduce breast cancer mortality. Not all women, however, come for examination. The objective in this study from Malmo has been to assess extent to which the rate of nonattendance varies between residential areas with different sociodemographic profiles. The study is based on 32,605 women, 45 to 68 years old and living in 17 areas, who between 1990 and 1994 were invited to screening. Between age groups, the age-specific nonattendance rate ranged from 31% to 35 % (P < .01). The nonattendance rate was highest for women 65 years or older. Between residential areas, age-adjusted nonattendance rates ranged from 23% to 43% (P < .01). A socioeconomic score was developed to express the socioeconomic circumstances in the residential areas and ranged from -7.18 in the most deprived area to 5.01 in the least. Nonattendance covaried in an inverse fashion with the socioeconomic score (r = -0.78; P < .01). One of three women in this urban population did not accept the invitation to mammographic screening. Our conclusion is that women in areas with less favorable circumstances seem to be less willing to participate.
  •  
49.
  • Nord, Maria (författare)
  • Levodopa pharmacokinetics -from stomach to brain A study on patients with Parkinson’s disease
  • 2017
  • Doktorsavhandling (övrigt vetenskapligt)abstract
    • Parkinsons sjukdom (PS) är en av de vanligaste s.k. neurodegenerativasjukdomarna och orsakas av förlust av dopamin(DA)producerande nervceller i hjärnan. Detta orsakar motoriska symptom såsom skakningar, stelhet och förlångsammade rörelser. Levodopa (LD) är ett ämne, som kan omvandlas till DA i hjärnan och ge symptomlindring och det är oftast förstahandsval vid behandling av patienter med PS. Flera faktorer påverkar tillgängligheten av LD, bl.a. den hastighet som magsäcken tömmer sig med och denna verkar förlångsammad hos personer med PS vilket ger sämre tillgänglighet av LD i blodet och därmed i hjärnan. LD bryts även ner i hög grad av olika enzym ute i kroppen vilket leder till mindre mängd LD som hamnar i hjärnan och till fler nedbrytningsprodukter som orsakar biverkningar. Tillägg av enzymhämmare leder till ökad mängd LD som kan nå hjärnan och omvandlas till DA. Det anses viktigt att undvika höga toppar av LD i hjärnan då dessa verkar bidra till utvecklandet av besvärliga motoriska komplikationer hos patienter med PS. Om LD ges mer kontinuerligt, exempelvis som en kontinuerlig infusion in i tarmen eller i blodet, så minskar dessa motoriska komplikationer. Inopererande av stimulatorer i vissa delar av hjärnan (DBS) har också visat sig minska dessa motoriska komplikationer och även resultera i att man kan minska LD-dosen.Huvudsyftet med den här avhandlingen är att studera LD hos patienter med PS; i blod och fettvävnad då LD ges i tablettform och se om det finns något samband med LD-upptag och hastigheten på magsäckstömningen (MT) och om kontinuerligt given LD påverkar LD-upptaget eller MT; i blod och i ryggmärgsvätska då enzymhämmarna entakapon och karbidopa tillsätts LD; i hjärna vid behandling med DBS och då LD ges både som tablett och som infusion i blodet.Sammanfattningsvis kan vi se att LD-upptaget är mer gynnsamt hos patienter med PS i tidigare skede av sjukdomens komplikationsfas. MT är förlångsammad hos patienter med PS och det är inget tydligt samband mellan LD-upptag och MT eller mellan MT och sjukdomsgrad. Kontinuerligt given LD minskar LDnivåerna. Enzymhämmaren entakapon ökar den maximala koncentrationen av LD i blod och ryggmärgsvätska och effekten är mer tydlig vid tillägg av karbidopa vilket är viktigt att ta i beaktande vid behandling av PS för att undvika höga toppar av LD i hjärnan. LD ökar i hjärnan då man behandlar med LD i tablettform och som infusion i blodet och DA-nivåerna i hjärnan följer LD väl vilket visar på att patienter med PS fortfarande kan omvandla LD till DA trots trolig uttalad brist av de DA-producerande nervcellerna i hjärnan. DBS verkar öka DA i vissa områden i hjärnan och tillsammans med LD-infusion i blodet verkar det även öka LD i hjärnan och det kan förklara varför man kan sänka LDdosen efter DBS-operation.
50.
  • Ramgren, B, et al. (författare)
  • Vertebrobasilar dissection with subarachnoid hemorrhage: a retrospective study of 29 patients.
  • 2005
  • Ingår i: Neuroradiology. - Springer. - 1432-1920. ; 47:2, s. 97-104
  • Tidskriftsartikel (refereegranskat)abstract
    • We have reviewed initial diagnostic features, treatment, and outcome in 29 patients with acute subarachnoid hemorrhage due to non-traumatic vertebrobasilar artery dissection diagnosed in our hospital between 1993 and 2003. The dissections occurred in the vertebral artery in 19 patients, the posterior inferior cerebellar artery ( PICA) in two patients, the basilar artery in four patients, and in the vertebral artery extending into the PICA in four patients. A pseudoaneurysm was found in 20 patients. Clinical manifestations typically included sudden onset of moderate to severe headache, nuchal rigidity, and drowsiness. Fourteen patients were treated conservatively. Fifteen patients underwent endovascular treatment with either parent artery occlusion ( 13 patients) or aneurysmal coil occlusion with preservation of the parent artery ( 2 patients). Re-bleeding occurred within 12 days and before treatment in nine patients. Eight of these had a pseudoaneurysm. No patient bled after endovascular treatment. Poor grade and early re-bleeding were associated with less favorable outcome. Outcome at 6 months did not differ significantly between endovascular and conservative treatment. Altogether, good recovery was achieved for 16 patients, moderate disability was seen in one, severe disability in four, and eight patients ( 27%) died. The absence of bleeding subsequent to endovascular treatment in this study suggests that endovascular treatment may be a rational approach in these patients at high risk of re-bleeding, especially those with a pseudoaneurysm.
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (22865)
Typ av publikation
tidskriftsartikel (79587)
konferensbidrag (5243)
doktorsavhandling (4823)
forskningsöversikt (3511)
bokkapitel (1906)
annan publikation (1271)
visa fler...
rapport (373)
bok (267)
samlingsverk (redaktörskap) (101)
licentiatavhandling (69)
recension (53)
proceedings (redaktörskap) (29)
patent (19)
konstnärligt arbete (7)
visa färre...
Typ av innehåll
refereegranskat (79674)
övrigt vetenskapligt (20171)
populärvet., debatt m.m. (427)
Författare/redaktör
Melander, Olle, (485)
Groop, Leif, (475)
Gillberg, Christophe ... (435)
Nilsson, Peter, (415)
Larsson, Anders, (414)
Sundquist, Jan, (413)
visa fler...
Riboli, Elio (407)
Sundquist, Kristina, (402)
Boeing, Heiner (384)
Overvad, Kim (375)
Tumino, Rosario (370)
Trichopoulou, Antoni ... (365)
Khaw, Kay-Tee (356)
Zetterberg, Henrik, ... (355)
Olsson, Håkan, (348)
Blennow, Kaj, 1958-, (343)
Swedberg, Karl, 1944 ... (341)
Kaaks, Rudolf (340)
Andersson, Roland, (337)
Hemminki, Kari, (315)
Engström, Gunnar, (310)
Tjonneland, Anne (308)
Wennergren, Göran, 1 ... (308)
Lind, Lars, (306)
Bruze, Magnus, (302)
Erlinge, David, (300)
Palli, Domenico (295)
Janson, Christer (291)
Forssell-Aronsson, E ... (287)
Ahren, Bo (282)
Lernmark, Åke, (276)
Stattin, Pär, (268)
Borg, Åke, (264)
Hansson, Oskar, (263)
Berntorp, Erik, (261)
Manjer, Jonas (258)
Bjermer, Leif, (257)
Sánchez, Maria-José (257)
Giwercman, Aleksande ... (256)
Minthon, Lennart, (255)
Sunnerhagen, Kathari ... (255)
Lohmander, Stefan, (254)
Norrving, Bo, (252)
Båth, Magnus, 1974-, (252)
Jirström, Karin, (250)
Karlsson, Jon, 1953- ... (246)
Glimelius, Bengt, (245)
Herlitz, Johan, (240)
Bueno-de-Mesquita, H ... (239)
Hallmans, Göran, (239)
visa färre...
Lärosäte
Lunds universitet (38675)
Göteborgs universitet (26251)
Uppsala universitet (16977)
Karolinska Institutet (13679)
Umeå universitet (11182)
Linköpings universitet (7386)
visa fler...
Örebro universitet (5338)
Stockholms universitet (1760)
Kungliga Tekniska Högskolan (1322)
Chalmers tekniska högskola (1191)
Högskolan i Jönköping (1083)
Linnéuniversitetet (742)
Högskolan Dalarna (616)
Malmö universitet (612)
Högskolan Kristianstad (589)
Högskolan i Borås (470)
Sveriges Lantbruksuniversitet (444)
Mittuniversitetet (419)
Högskolan i Skövde (411)
Högskolan i Halmstad (304)
Mälardalens högskola (265)
Sophiahemmet Högskola (255)
Högskolan Väst (239)
Karlstads universitet (216)
Röda Korsets Högskola (186)
Ersta Sköndal Bräcke högskola (185)
Högskolan i Gävle (182)
Luleå tekniska universitet (179)
Gymnastik- och idrottshögskolan (161)
Blekinge Tekniska Högskola (131)
RISE (91)
Södertörns högskola (86)
VTI - Statens väg- och transportforskningsinstitut (18)
Försvarshögskolan (3)
Stockholms konstnärliga högskola (3)
Naturhistoriska riksmuseet (3)
Konstfack (2)
swepub_uni:mau_t (2)
Nordiska Afrikainstitutet (2)
visa färre...
Språk
Engelska (91076)
Svenska (4562)
Tyska (117)
Danska (47)
Odefinierat språk (36)
Franska (35)
visa fler...
Spanska (35)
Norska (33)
Finska (33)
Portugisiska (31)
Annat språk (15)
Isländska (14)
Italienska (12)
Kinesiska (10)
Polska (7)
Ryska (6)
Japanska (5)
Tjeckiska (4)
Ungerska (3)
Turkiska (3)
Nederländska (2)
Arabiska (1)
Estniska (1)
Rumänska (1)
Nygrekiska (1)
Ukrainska (1)
Esperanto (1)
Bosniska (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (97244)
Samhällsvetenskap (3105)
Naturvetenskap (2102)
Teknik (1111)
Humaniora (429)
Lantbruksvetenskap (239)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy